Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Dr. Wolinsky join the staff of Cleveland Clinic Florida in 2011. He received his undergraduate and M.D. degrees from Columbia University. He carried out his postgraduate training and then spent seven years on staff at St. Luke's Hospital in New York City before joining Albany Associates in Cardiology in Albany, New York where worked from 1989 through 2011. Dr. Wolinsky was director of nuclear cardiology from 1991-2011. He was director of heart failure and director of cardiac Rehabilitation and Wellness at St. Peter's Hospital prior to his arrival at Cleveland clinic.
Dr. Wolinsky is a leader in nuclear cardiology. He is a founding member of the American Society of Nuclear Cardiology. He is a member of its the Board of Directors is and its quality assurance committee. He is an active teacher and lectures at both regional and national meetings. He is actively involved in clinical nuclear cardiology research. He is the founder of the Nuclear Cardiology department at Albany Associates in Cardiology.
Dr. Wolinsky is also involved in heart failure management. He was medical director of the heart failure program at St. Peter's Hospital prior to joining Cleveland Clinic Florida. He was responsible for nursing education and was in charge of the Heart Failure Quality Assurance program.
Dr. Wolinsky is is a champion for community education for heart disease. He lectured frequently on cardiovascular risk reduction and heart failure as part of his role as director of Cardiac Rehab and Wellness.
Nuclear cardiology, heart failure, prevention
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland
Clinic's procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. The Cleveland Clinic requires its doctors to approve the public disclosures of their scientific collaborations with industry. As of 8/31/2014 the review process regarding Dr. Wolinsky's disclosure had not been completed. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.